Bionano Genomics (NASDAQ:BNGO) Given New $4.00 Price Target at Scotiabank
Bionano Genomics (NASDAQ:BNGO – Get Free Report) had its price objective raised by stock analysts at Scotiabank from $1.00 to $4.00 in a note issued to investors on Wednesday,Benzinga reports. The brokerage currently has a “sector perform” rating on the stock. Scotiabank’s price objective suggests a potential upside of 19.05% from the company’s previous close. […]
